SCHEMBL19085872

SCHEMBL19085872

CCc1cc2cc[nH]c2cc1C(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 1/20 0.40
CFTR P13569 1/20 0.38
TAS1R3 Q7RTX0 1/20 0.38
TAS1R1 Q7RTX1 1/20 0.38
PTGS2 P35354 1/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPT P10636 1/20 0.37
MAOA P21397 3/20 0.36
CYP2A6 P11509 3/20 0.36
CSNK2A1 P68400 1/20 0.36
MEN1 O00255 1/20 0.36
POLB P06746 1/20 0.36
MAPK1 P28482 1/20 0.36
KMT2A Q03164 1/20 0.36
CTNNB1 P35222 1/20 0.36
WNT3A P56704 1/20 0.36
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35
SLC6A3 Q01959 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22433008 0.93 TAS1R3 (0.40) GPR84CFTRTAS1R3TAS1R1PTGS2
SCHEMBL10289632 0.81 GPR84 (0.48) GPR84CFTRKDM4EALDH1A1MAPT
SCHEMBL16744197 0.81 GPR84 (0.48) GPR84PTGS2MAPTCYP2A6CSNK2A1
SCHEMBL20808176 0.78 GPR84 (0.39) GPR84CFTRTAS1R3TAS1R1PTGS2
SCHEMBL14845723 0.77 GPR84 (0.44) GPR84CFTRKDM4EALDH1A1MAPT
SCHEMBL15763108 0.75 CSNK2A1 (0.50) GPR84PTGS2MAPTMAOACYP2A6
SCHEMBL394958 0.75 GPR84 (0.42) GPR84CFTRKDM4EALDH1A1MAPT
SCHEMBL8526792 0.75 CSNK2A1 (0.55) GPR84CFTRKDM4EALDH1A1MAPT
SCHEMBL8959604 0.75 GPR84 (0.62) GPR84PTGS2CYP2A6CSNK2A1MEN1
SCHEMBL17920373 0.75 GPR84 (0.62) GPR84CFTRKDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9974781-B2 Modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2018-05-22 US disclosed
US-20170189389-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED (US) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170189389-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS CFTR, ABCB1, ABCC2 GPR84 409/4885CFTR 1/4885TAS1R3 2184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.